RMDA.CA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 29, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA)

Based on 11 analysts giving stock ratings to Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) in the past 3 months

Strong
SellSellHoldBuyStrong
Buy
Strong Buy
36
Buy
55
Hold
9
Sell
0
Strong Sell
0
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE)

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE). Stock Analysis RMDA.CA

Egypt Health Care Micro Cap Report:
Tenth of Ramadan Company for Pharmaceuticals Industries & Diagnostic Reagents S.A.E. The company is headquartered in Giza, Giza. The company went IPO on 2019-11-27. The company operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others. The firm owns an extensive product portfolio covering anti-infective, anti-diabetic, respiratory, ophthalmology, gastro-intestinal tract, cardio-vascular, central nervous system, vitamins and analgesics. Additionally, the Company provides contract manufacturing services to a number of local and multinational pharmaceutical companies.
Read More

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA) Chart

Key Statistics of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

EGP5.06EGP5.15

Today's Open

EGP5.09

Volume

7.28M

P/E Ratio (TTM)

34.38

52 Week Range

EGP3.02EGP5.18

Market Cap

8.80B

Avg. Volume

14.26M

Dividend Yield

1.84%

Financial Metrics & Statements of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA)

FAQ's for Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA)

  • According to Musaffa’s Shariah screening methodology, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) (RMDA.CA) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.